Feb. 9, 2024 Price forecast | 2 weeks: -3.27% | 1 month: -6.45% | 3 months: -9.22%


ABEO stock forecast

Our latest prediction for Abeona Therapeutics Inc's stock price was made on the Feb. 9, 2024 when the stock price was at 6.20$.

In the short term (2weeks), ABEO's stock price should underperform the market by -3.27%. During that period the price should oscillate between -18.69% and +11.41%.

In the medium term (3months), ABEO's stock price should underperform the market by -9.22%. During that period the price should oscillate between -52.71% and +22.86%.

Create a solid portfolio with ABEO

Add ABEO to your portfolio and optimize it!


About Abeona Therapeutics Inc

abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t

At the moment the company generates 19M USD in revenues.

On its last earning announcement, the company reported a loss of -1.93$ per share.

The book value per share is 3.36$

Abeona Therapeutics Inc website


Three months stock forecastFeb. 9, 2024


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
19M - -46M - -38M -1.93 - - 24M 3.36 - - -